Clinical Trials Browser

Phase 2 × Ependymoma × Carboplatin × Clear all

Brain Neoplasms, Ependymoma, Neoplasms, Neurologic Manifestations, Spinal Cord Neoplasms

NCT00528437 2021-07-08

Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

Phase 2 Completed

46 enrolled 5 charts

CNS

Brain Neoplasms, Ependymoma, Glioma, Recurrence

NCT01088035 2015-03-02

Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma

Phase 2 Terminated

75 enrolled

Familial ependymoma, Ependymoma

NCT00541138 2011-09-21

Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors

Phase 2 Completed

50 enrolled

CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Neoplasm Metastasis, Oligodendroglioma, Central Nervous System Neoplasms, Glioma, Subependymal, Gliosarcoma

Clinical Trials

Carboplatin and Bevacizumab for Recurrent Ependymoma

Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma

Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors